Innate immunity and organ transplantation: Focus on lung transplantation

Transplant International

Volumn 26, Issue 1, 2013, Pages 2-10

  Kreisel, Daniel ^a   Goldstein, Daniel R ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

immunobiology; organ transplantation

Indexed keywords

INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; CD8+ T LYMPHOCYTE; DENDRITIC CELL; DNA POLYMORPHISM; HUMAN; INNATE IMMUNITY; LUNG TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; TRANSPLANTATION TOLERANCE;

ANIMALS; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; LUNG TRANSPLANTATION; REPERFUSION INJURY; TOLL-LIKE RECEPTOR 4;

EID: 84871265266     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01549.x     Document Type: Review

References (80)

1. Krieger NR, Yin DP, Fathman CG,. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 1996; 184: 2013.
2. Sicard A, Phares TW, Yu H, etal. The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients. Am J Trans 2012; 12: 1708.
3. Lefaucheur C, Nochy D, Hill GS, etal. Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 2007; 7: 832.
4. Eltzschig HK, Eckle T,. Ischemia and reperfusion from mechanism to translation. Nat Med 2011; 17: 1391.
5. Iwasaki A, Medzhitov R,. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987.
6. Kawai T, Akira S,. Toll-like receptor and RIG-1-like receptor signaling. Ann N Y Acad Sci 2008; 1143: 1.
7. Akira S, Uematsu S, Takeuchi O,. Pathogen recognition and innate immunity. Cell 2006; 124: 783.
8. Zhai Y, Shen X-d, O'Connell R, etal. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004; 173: 7115.
9. Shen X-D, Ke B, Zhai Y, etal. Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Trans 2005; 5: 1793.
10. Tsung A, Sahai R, Tanaka H, etal. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005; 201: 1135.
11. Izuishi K, Tsung A, Jeyabalan G, etal. Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury. J Immunol 2006; 176: 7154.
12. Shishido T, Nozaki N, Yamaguchi S, etal. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 2003; 108: 2905.
13. Oyama J-i, Blais C, Jr, Liu X, etal. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 2004; 109: 784.
14. Kaczorowski DJ, Nakao A, Mollen KP, etal. Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion. Transplantation 2007; 84: 1279.
15. Kaczorowski DJ, Nakao A, Vallabhaneni R, etal. Mechanisms of toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation 2009; 87: 1455.
16. Favre J, Musette P, Douin-Echinard V, etal. Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol 2007; 27: 1064.
17. Boyd JH, Mathur S, Wang Y, Bateman RM, Walley KR,. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-κB dependent inflammatory response. Cardiovasc Res 2006; 72: 384.
18. Leemans JC, Stokman G, Claessen N, etal. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005; 115: 2894.
19. Wu H, Chen G, Wyburn KR, etal. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847.
20. Wu H, Ma J, Wang P, etal. HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol 2010; 21: 1878.
21. Farrar CA, Keogh B, McCormack W, etal. Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury. FASEB J 2012; 26: 799.
22. Goldstein DR, Tesar BM, Akira S, Lakkis FG,. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003; 111: 1571.
23. Tesar BM, Zhang J, Li Q, Goldstein DR,. TH1 immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a toll like receptor signal adaptor protein. Am J Transplant 2004; 4: 1429.
24. McKay D, Shigeoka A, Rubinstein M, Surh C, Sprent J,. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Euro J Immunol 2006; 36: 1994.
25. Noris M, Cassis P, Azzollini N, etal. The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts. J Immunol 2009; 183: 4249.
26. Goldberg A, Parolini M, Chin BY, etal. Toll-like receptor 4 suppression leads to islet allograft survival. FASEB J 2007; 21: 2840.
27. Hutton MJH, Westwell-Roper C, Soukhatcheva G, Plesner A, Dutz JP, Verchere CB,. Islet allograft rejection is independent of toll-like receptor signaling in mice. Transplantation 2009; 88: 1075.
28. Zhang N, Krüger B, Lal G, etal. Inhibition of TLR4 signaling prolongs Treg-dependent murine islet allograft survival. Immunol Lett 2010; 127: 119.
29. Krams SM, Wang M, Castillo RO, etal. Toll-like receptor 4 contributes to small intestine allograft rejection. Transplantation 2010; 90: 1272.
30. Wang S, Schmaderer C, Kiss E, etal. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling. Dis Model Mech 2010; 3: 92.
31. Methe H, Zimmer E, Grimm C, Nabauer Ma, Koglin J,. Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 2004; 78: 1324.
32. Li H, Matte-Martone C, Tan HS, etal. Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells. J Immunol 2011; 186: 230.
33. Calcaterra C, Sfondrini L, Rossini A, etal. Critical role of TLR9 in acute graft-versus-host disease. J Immunol 2008; 181: 6132.
34. Imado T, Iwasaki T, Kitano S, etal. The protective role of host toll-like receptor-4 in acute graft-versus-host disease. Transplantation 2010; 90: 1063.
35. Cooke KR, Hill GR, Crawford JM, etal. Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest 1998; 102: 1882.
36. Palmer SM, Burch LH, Davis RD, etal. The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med 2003; 168: 628.
37. Palmer SM, Burch LH, Trindade AJ, etal. Innate immunity influences long-term outcomes after human lung transplant. Am J Respir Crit Care Med 2005; 171: 780.
38. Palmer SM, Klimecki W, Yu L, etal. Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14. Am J Trans 2007; 7: 693.
39. Ducloux D, Deschamps M, Yannaraki M, etal. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 2005; 67: 2454.
40. Kruger B, Krick S, Dhillon N, etal. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA 2009; 106: 3390.
41. Testro AG, Visvanathan K, Skinner N, etal. Acute allograft rejection in human liver transplant recipients is associated with signaling through toll-like receptor 4. J Gastroenterol Hepatol 2011; 26: 155.
42. Walker WE, Nasr IW, Camirand G, Tesar BM, Booth CJ, Goldstein DR,. Absence of innate MyD88 signaling promotes inducible allograft acceptance. J Immunol 2006; 177: 5307.
43. Chen L, Wang T, Zhou P, etal. TLR engagement prevents transplantation tolerance. Am J Transplant 2006; 6: 2282.
44. Braudeau C, Ashton-Chess J, Giral M, etal. Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients. Transplantation 2008; 86: 130.
45. Porrett PM, Yuan X, LaRosa DF, etal. Mechanisms underlying blockade of allograft acceptance by TLR ligands. J Immunol 2008; 181: 1692.
46. Thornley TB, Brehm MA, Markees TG, etal. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts. J Immunol 2006; 176: 1561.
47. Shen H, Goldstein DR,. IL-6 and TNF-{alpha} synergistically inhibit allograft acceptance. J Am Soc Nephrol 2009; 5: 1032.
48. Zhao X, Boenisch O, Yeung M, etal. Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance. AM J Trans 2011; 12: 90.
49. Goldstein DR,. The identity of innate immune activators in organ transplantation: origins from within or exterior to the host?. Am J Trans 2007; 7: 1692.
50. Chen GY, Nuñez G,. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010; 10: 826.
51. Rock KL, Hearn A, Chen CJ, Y S,. Natural endogenous adjuvants. Springer Semin Immunopathol 2005; 26: 231.
52. Ahrens S, Zelenay S, Sancho D, etal. F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity 2012; 36: 635.
53. Zhang J-G, Czabotar Peter E, Policheni Antonia N, etal. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity 2012; 36: 646.
54. Shen H, Song Y, Colangelo CM, etal. Haptoglobin activates innate immunity to enhance acute transplant rejection in mice. J Clin Invest 2012; 122: 383.
55. Quaye IK,. Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg 2008; 102: 735.
56. Wang Y, Kinzie E, Berger FG, SK L, Baumann H,. Haptoglobin, an inflammation-inducible plasma protein. Redox Rep 2001; 6: 379.
57. de Kleijn D, Smeets M, Kemmeren P, etal. Acute-phase protein haptoglobin is a cell migration factor involved in arterial restructuring. FASEB J 2002; 16: 1123.
58. Huntoon KM, Wang Y, Eppolito CA, etal. The acute phase protein haptoglobin regulates host immunity. J Leukoc Biol 2008; 84: 170.
59. Arredouani MS, Kasran A, Vanoirbeek JA, Berger FG, Baumann H, Ceuppens JL,. Haptoglobin dampens endotoxin-induced inflammatory effects both in vitro and in vivo. Immunology 2005; 114: 263.
60. Kreisel D, Krupnick AS, Puri V, etal. Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center. J Thorac Cardiovasc Surg 2011; 141: 215.
61. Shimamoto A, Pohlman TH, Shomura S, Tarukawa T, Takao M, Shimpo H,. Toll-like receptor 4 mediates lung ischemia-reperfusion injury. Ann Thorac Surg 2006; 82: 2017.
62. Zanotti G, Casiraghi M, Abano JB, etal. Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema. Am J Physiol Lung Cell Mol Physiol 2009; 297: L52.
63. Andrade CF, Kaneda H, Der S, etal. Toll-like receptor and cytokine gene expression in the early phase of human lung transplantation. J Heart Lung Transplant 2006; 25: 1317.
64. Tesar BM, Jiang D, Liang J, Palmer SM, Noble PW, Goldstein DR,. The role of hyaluronan degradation products as innate alloimmune agonists. Am J Transplant 2006; 6: 2622.
65. Naidu BV, Krishnadasan B, Farivar AS, etal. Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2003; 126: 200.
66. Zhao M, Fernandez LG, Doctor A, etal. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 2006; 291: L1018.
67. Sharma AK, Fernandez LG, Awad AS, Kron IL, Laubach VE,. Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 2007; 293: L105.
68. Sharma AK, LaPar DJ, Zhao Y, etal. Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am J Respir Crit Care Med 2011; 183: 1539.
69. Okazaki M, Krupnick AS, Kornfeld CG, etal. A mouse model of orthotopic vascularized aerated lung transplantation. Am J Trans 2007; 7: 1672.
70. Kreisel D, Sugimoto S, Tietjens J, etal. Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis. J Clin Invest 2011; 121: 265.
71. Thabut G, Mal H, Cerrina J, etal. Graft ischemic time and outcome of lung transplantation: a multicenter analysis. Am J Respir Crit Care Med 2005; 171: 786.
72. Kreisel D, Nava RG, Li W, etal. In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation. Proc Natl Acad Sci USA 2010; 107: 18073.
73. Gelman AE, Okazaki M, Sugimoto S, etal. CCR2 regulates monocyte recruitment as well as CD4+ th1 allorecognition after lung transplantation. AM J Trans 2010; 10: 1189.
74. Sugimoto S, Lin X, Okazaki M, etal. Monocyte differentiation is controlled by myd88 after mouse orthotopic lung transplantation. Transpl Proc 2009; 41: 388.
75. Gelman AE, Li W, Richardson SB, etal. Cutting edge: acute lung allograft rejection is independent of secondary lymphoid organs. J Immunol 2009; 182: 3969.
76. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y,. Immunologic/'ignorance/' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000; 6: 686.
77. Kreisel D, Sugimoto S, Zhu J, etal. Emergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance. Blood 2011; 118: 6172.
78. Gottlieb J, Mattner F, Weissbrodt H, etal. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis. Respir Med 2009; 103: 743.
79. Khalifah AP, Hachem RR, Chakinala MM, etal. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004; 170: 181.
80. Botha P, Archer L, Anderson RL, etal. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 2008; 85: 771.